Dual immune checkpoint blockade of LILRB1 and CD47 enhances antibody-dependent cellular phagocytosis of lymphoma cells by CD20 antibodies

Zeller T, Lutz S, Muennich IA, Windisch R, Hilger P, Herold T, Tahiri N, Banck JC, Weigert O, Moosmann A, Von Bergwelt-Baildon M, Bruns H, Wichmann C, Valerius T, Schewe DM, Peipp M, Roesner T, Humpe A, Kellner C (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

European Journal of Immunology Wiley-VCH Verlag

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 136-137

Conference Proceedings Title: EUROPEAN JOURNAL OF IMMUNOLOGY

Authors with CRIS profile

Heiko Bruns Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Otto-von-Guericke-Universität Magdeburg DE Germany (DE) Christian-Albrechts-Universität zu Kiel DE Germany (DE) Ludwig-Maximilians-Universität (LMU) DE Germany (DE)

How to cite

APA:

Zeller, T., Lutz, S., Muennich, I.A., Windisch, R., Hilger, P., Herold, T.,... Kellner, C. (2022). Dual immune checkpoint blockade of LILRB1 and CD47 enhances antibody-dependent cellular phagocytosis of lymphoma cells by CD20 antibodies. In EUROPEAN JOURNAL OF IMMUNOLOGY (pp. 136-137). HOBOKEN: WILEY.

MLA:

Zeller, T., et al. "Dual immune checkpoint blockade of LILRB1 and CD47 enhances antibody-dependent cellular phagocytosis of lymphoma cells by CD20 antibodies." Proceedings of the EUROPEAN JOURNAL OF IMMUNOLOGY HOBOKEN: WILEY, 2022. 136-137.

BibTeX: Download